Company Filing History:
Years Active: 2012
Title: Warren R. Mikluka: Innovator in Antibody Development
Introduction
Warren R. Mikluka is a notable inventor based in Brewster, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of high-affinity human antibodies.
Latest Patents
Mikluka holds a patent for "High affinity human antibodies to human IL-18 receptor." This patent describes an isolated antibody or antibody fragment that binds to the human interleukin-18 receptor alpha (hIL-18Rα). The invention includes a light chain variable region (LCVR) selected from a specific group of sequences and/or a heavy chain variable region (HCVR) from another defined group, allowing for modifications through amino acid substitutions, deletions, or additions.
Career Highlights
Warren R. Mikluka is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to advance his research in antibody development. His work has the potential to impact therapeutic approaches in various medical conditions.
Collaborations
Mikluka collaborates with talented professionals in his field, including Tammy H. Huang and Sean Stevens. Their combined expertise contributes to the innovative environment at Regeneron Pharmaceuticals.
Conclusion
Warren R. Mikluka's contributions to antibody research exemplify the importance of innovation in biotechnology. His patent and ongoing work at Regeneron Pharmaceuticals highlight his role as a key figure in advancing medical science.